These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


199 related items for PubMed ID: 2939362

  • 1. Dopamine D2 receptors and dopamine metabolism. Relationship between biochemical and behavioural effects of substituted benzamide drugs.
    Magnusson O, Fowler CJ, Köhler C, Ogren SO.
    Neuropharmacology; 1986 Feb; 25(2):187-97. PubMed ID: 2939362
    [Abstract] [Full Text] [Related]

  • 2. Definition of the in-vivo accumulation of [3H]spiperone in brain using haloperidol and sulpiride to determine functional dopamine receptor occupation.
    Chivers JK, Reavill C, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1988 Sep; 40(9):613-9. PubMed ID: 2907027
    [Abstract] [Full Text] [Related]

  • 3. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
    Ogren SO, Hall H, Köhler C, Magnusson O, Lindbom LO, Angeby K, Florvall L.
    Eur J Pharmacol; 1984 Jul 20; 102(3-4):459-74. PubMed ID: 6149133
    [Abstract] [Full Text] [Related]

  • 4. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.
    Ogren SO, Hall H, Köhler C, Magnusson O, Sjöstrand SE.
    Psychopharmacology (Berl); 1986 Jul 20; 90(3):287-94. PubMed ID: 2947255
    [Abstract] [Full Text] [Related]

  • 5. Effect of long-term dosing with tiapride on brain dopamine receptors and metabolism in rats. Comparative study with sulpiride and haloperidol.
    Satoh H, Kuwaki T, Shirakawa K, Kohjimoto Y, Ono T, Shibayama F, Nomura Y.
    Jpn J Pharmacol; 1987 Aug 20; 44(4):393-403. PubMed ID: 3682405
    [Abstract] [Full Text] [Related]

  • 6. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
    Hall MD, Cooper DR, Fleminger S, Rupniak NM, Jenner P, Marsden CD.
    Neuropharmacology; 1984 May 20; 23(5):545-53. PubMed ID: 6539859
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O, Mohringe B, Fowler CJ.
    J Neural Transm; 1987 May 20; 69(3-4):163-77. PubMed ID: 2957465
    [Abstract] [Full Text] [Related]

  • 8. Studies on the mechanism of action of substituted benzamide drugs.
    Köhler C, Ogren SO, Fuxe K.
    Acta Psychiatr Scand Suppl; 1984 May 20; 311():125-37. PubMed ID: 6142588
    [Abstract] [Full Text] [Related]

  • 9. Effects of the dopamine D2 selective receptor antagonist remoxipride on dopamine turnover in the rat brain after acute and repeated administration.
    Magnusson O, Mohringe B, Thorell G, Lake-Bakaar DM.
    Pharmacol Toxicol; 1987 May 20; 60(5):368-73. PubMed ID: 2886989
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of haloperidol, remoxipride and raclopride on "pre"- and postsynaptic dopamine receptors in the rat brain.
    Magnusson O, Fowler CJ, Mohringe B, Wijkström A, Ogren SO.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr 20; 337(4):379-84. PubMed ID: 2900472
    [Abstract] [Full Text] [Related]

  • 11. Definition of the in-vivo binding of [3H]spiperone in rat brain using substituted benzamide drugs.
    Chivers JK, Reavill C, Jenner P, Marsden CD.
    J Pharm Pharmacol; 1989 Feb 20; 41(2):106-11. PubMed ID: 2568417
    [Abstract] [Full Text] [Related]

  • 12. Prevention of neuroleptic-induced dopamine D2 receptor supersensitivity by chronic iron salt treatment.
    Ben-Shachar D, Pinhassi B, Youdim MB.
    Eur J Pharmacol; 1991 Sep 17; 202(2):177-83. PubMed ID: 1687031
    [Abstract] [Full Text] [Related]

  • 13. Brain dopamine D-2 receptor mechanisms in spontaneously hypertensive rats.
    Van den Buuse M, Jones CR, Wagner J.
    Brain Res Bull; 1992 Feb 17; 28(2):289-97. PubMed ID: 1375862
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of the novel antipsychotic agent remoxipride on dopamine and noradrenaline turnover in the rat brain.
    Magnusson O, Fowler CJ.
    Pharmacol Toxicol; 1989 Oct 17; 65(4):295-8. PubMed ID: 2573899
    [Abstract] [Full Text] [Related]

  • 15. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S, Kelly E, Davis A, Fleminger S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1985 May 15; 34(10):1665-9. PubMed ID: 2988552
    [Abstract] [Full Text] [Related]

  • 16. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
    Fleminger S, Rupniak NM, Hall MD, Jenner P, Marsden CD.
    Biochem Pharmacol; 1983 Oct 01; 32(19):2921-7. PubMed ID: 6138043
    [Abstract] [Full Text] [Related]

  • 17. Striatal dopamine receptor sensitivity after subchronic fencamfamine in the rat.
    Scavone C, De Lucia R, Bernardi MM, Aizenstein ML.
    Eur J Pharmacol; 1985 May 28; 112(1):11-6. PubMed ID: 4040467
    [Abstract] [Full Text] [Related]

  • 18. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
    Jenner P, Rupniak NM, Marsden CD.
    Psychopharmacology Suppl; 1985 May 28; 2():174-81. PubMed ID: 3159009
    [Abstract] [Full Text] [Related]

  • 19. [Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent].
    Ogren SO, Hall H, Köhler C, Magnusson O, Florvall L.
    Arzneimittelforschung; 1985 May 28; 35(8):1227-31. PubMed ID: 2866774
    [Abstract] [Full Text] [Related]

  • 20. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra.
    Wedzony K, Czyrak A, Maćkowiak M, Fijał K.
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr 28; 353(5):517-27. PubMed ID: 8740145
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.